Table 3.
Effect of HBEO and HBEON on serum biochemical parameters in rats treated with TiO2-NPs
| Groups parameter | Control | HBEO | HBEON | TiO2-NPs | TiO2-NPs + HBEO | TiO2-NPs + HBEON |
|---|---|---|---|---|---|---|
| ALT (U/L) | 44.23 ± 1.06a | 44.58 ± 0.56a | 42.93 ± 1.03b | 86.41 ± 2.27c | 62.19 ± 1.81d | 52.37 ± 0.43e |
| AST (U/L) | 145.11 ± 1.38a | 145.38 ± 0.71a | 139.17 ± 2.86b | 204.51 ± 2.38c | 159.96 ± 1.51d | 159.71 ± 1.06d |
| Alb (g/dl) | 2.84 ± 0.03a | 2.55 ± 0.10b | 2.88 ± 0.04a | 1.14 ± 0.03c | 2.21 ± 0.07d | 2.03 ± 0.05e |
| TP (g/dl) | 6.26 ± 0.18a | 6.26 ± 0.10a | 6.82 ± 0.05b | 5.22 ± 0.24c | 5.46 ± 0.09d | 6.09 ± 0.08a |
| T.BIL (g/dl) | 0.89 ± 0.02a | 0.83 ± 0.02a | 0.80 ± 0.02a | 1.54 ± 0.21a | 1.13 ± 0.02a | 0.95 ± 0.04a |
| D.BIL (g/dl) | 0.19 ± 0.02a | 0.21 ± 0.01a | 0.22 ± 0.01a | 0.38 ± 0.02c | 0.30 ± 0.01d | 0.28 ± 0.02d |
| Creatinine (g/dl) | 1.14 ± 0.03a | 0.85 ± 0.04ab | 0.86 ± 0.03b | 2.52 ± 0.11c | 1.94 ± 0.02d | 1.81 ± 0.04e |
| Uric acid (mg/dl) | 2.26 ± 0.21a | 1.46 ± 0.07b | 1.46 ± 0.06b | 4.17 ± 0.24c | 2.59 ± 0.09d | 2.47 ± 0.10e |
| Urea (mg/dl) | 56.21 ± 1.38a | 53.44 ± 0.41a | 52.31 ± 0.43a | 81.32 ± 1.51b | 70.32 ± 0.78c | 59.85 ± 0.57d |
Within each column, means superscript with different letters are significantly different (p < 005)